• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Welcome to the Gilead Sciences Board

Status
Not open for further replies.

cafead

Administrator
Staff member
  • cafead   Dec 08, 2004 at 11:15: AM
Welcome to the Gilead Sciences company board. Anyone is welcome to post here, whether they are an employee of the company or not. You may post anonymously without registering (registered users please logout before posting if you wish to do so), or with a registered username.

Managers and reps are encouraged to communicate with fellow employees here. If you are interested, we can also provide you with a private, password-protected board for your pod, district, etc. Just email webmaster@cafepharma.com for the details.
 




Status
Not open for further replies.